Asset
ACLERASTIDE
Integra LifeSciences Holdings Corporation Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (2)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT01849965 | phase3 | terminated | 2013-04-01 | 2015-12-01 | Integra LifeSciences Corporation | Phase 3 Study Evaluating Efficacy and Safety of DSC127 Compared With Vehicle and With Standard-of-care in Diabetic Foot Ulcers |
| NCT01830348 | phase3 | terminated | 2013-02-01 | 2015-12-01 | Integra LifeSciences Corporation | Phase III Study to Evaluate Efficacy and Safety of DSC127 in Diabetic Foot Ulcers |
FDA applications (0)
This company has no applications containing this asset.